Oxyextras maintains a narrowly scoped product line centered on a single application where the durable signal reflects web-layer input-handling issues, particularly cross-site scripting vulnerabilities. Current severity, exploitation activity, and exposure counts are shown alongside this summary.
The number and severity of CVEs published that impact products developed by Oxyextras over time
Signals from CVEs in this vendor scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2024-29129MEDIUM Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in WPLIT Pty Ltd OxyExtras allows Reflected XSS.This issue affects OxyExtras: fro | Mar 19, 2024 | 6.1 | 18 | NO | NO |
Signals from CVEs in this vendor scope (1 CVEs).
An overview of all social media posts that mention a CVE ID that affects a product developed by Oxyextras.
Media articles that mention a CVE ID that affects a product developed by Oxyextras — matched by CVE ID, not by vendor name.